Luo Jingfeng, Luo Yuxuan, Sun Jihong, Zhou Yurong, Zhang Yajing, Yang Xiaoming
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Qingchun Road NO.3, Hangzhou, Zhejiang, China.
Department of Nephrology, Zhuji People's Hospital, Zhuji, Zhejiang, China.
Cancer Lett. 2015 Jan 28;356(2 Pt B):347-56. doi: 10.1016/j.canlet.2014.10.045. Epub 2014 Nov 10.
Gene therapy is one of the frontiers of modern medicine. Adeno-associated virus (AAV)-mediated gene therapy is becoming a promising approach to treat a variety of diseases and cancers. AAV-mediated cancer gene therapies have rapidly advanced due to their superiority to other gene-carrying vectors, such as the lack of pathogenicity, the ability to transfect both dividing and non-dividing cells, low host immune response, and long-term expression. This article reviews and provides up to date knowledge on AAV-mediated cancer gene therapy.
基因治疗是现代医学的前沿领域之一。腺相关病毒（AAV）介导的基因治疗正成为治疗多种疾病和癌症的一种有前景的方法。由于AAV介导的癌症基因治疗相对于其他基因载体具有优势，如无致病性、能够转染分裂细胞和非分裂细胞、宿主免疫反应低以及长期表达，因此其发展迅速。本文回顾并提供了关于AAV介导的癌症基因治疗的最新知识。
